Kezar Life Sciences Inc (KZR)

$9.76 0.28 (2.79%)
16:00 EDT KZR Stock Quote Delayed 30 Minutes

Kezar Life Sciences (KZR) Stock Soars on Lupus Trial Results

Shares of Kezar Life Sciences are up an astounding 74% today after the biotechnology company reported positive results from its clinical trial regarding a treatment for the autoimmune disease Lupus.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Billionaire Israel Englander Is Betting Big on These 5 Stocks

3 Biotech Stocks to Buy Before They Boom

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 589.66M
PE Ratio -9.30
EPS -1.05
Volume (Avg. Vol.) 846,995
Day's Range $9.64 - $10.36
52-Week Range $4.31 - $18.55
Dividend & Yield N/A (N/A)